共 24 条
[3]
Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials
[J].
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE,
2005, 59 (01)
:8-16
[6]
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy
[J].
BLOOD COAGULATION & FIBRINOLYSIS,
2006, 17 (05)
:389-395